General Method for Preparing Ammonium Salts 3a, 3b, 6a, 6b, 9a, 9b. Trolox 2-hydroxymethyl mono- or
disuccinate or ꢀ-tocopherol succinate (17.5–26.5 mg, ~0.05 mmol) in THF (EtOAc) (0.5 mL) was treated with a solution of
the appropriate amine a or b (~0.1 mmol for 2 and 5; 0.05 mmol for 8) in THF (EtOAc) (0.3 mL). The mixtures were
evaporated after 16–20 h. The viscous residue was triturated with Et O to form a powder or viscous liquid that was filtered
2
off, rinsed with EtOAc, and dried to constant weight.
1
-Oxyl-2,2,6,6-tetramethylpiperidine-4-ammonium 6-(3-Carboxylatopropanoyloxy)-2,5,7,8-tetramethyl-
–1
chromane-2-carboxylate (3a). Orange powder, yield 34.3 mg (99%), mp 95.4°C (dec.). C H N O . IR spectrum (ꢃ, cm ):
396 and 1641 (COO ), 1556 (ꢂN–H), 1738 (ester COO). EPR spectrum: a = 16.0 G.
36 60 4 9
–
1
N
bis(2-Hydroxyethyl)ammonium 6-(3-Carboxylatopropanoyloxy)-2,5,7,8-tetramethylchromane-2-carboxylate
–
1
–
(
1
3b). Viscous white liquid, yield 26.6 mg (95%). C H N O . IR spectrum (ꢃ, cm ): 1400 and 1620 (COÎ ), 1574 (ꢂN–H),
24 44 2 11
1
745 (ester COO). Í NMR spectrum (400 MHz, CD OD, ꢂ, ppm): 1.58 (3Í, s, ÑÍ -2), 1.96 (3Í, s), 2.03 (3Í, s), 2.19 (3Í, s)
3 3
–
ÑÍ -5, 7, 8, 1.71–1.79 (1Í, m, H-3), 2.43–2.52 (1Í, m, Í-3), 2.59–2.68 (4Í, m) and 2.87–2.92 (2Í, m) – Í-4 and
3
1
3
succinyl CH ; 3.04–3.08 (8Í, m), 3.74–3.78 (8Í, m) – diethanolamine CH . C NMR spectrum (75 MHz, CD OD, ꢂ, ppm):
2
2
3
1
2.19, 12.24, 13.15 (ÑÍ -5, 7, 8), 22.49, 26.02, 32.01, 31.21, 32.77 (Ñ-3, 4, ÑÍ -2, succinyl CH ), 50.47, 57.92 (diethanolamine
3
3
2
CH ); 80.13 (Ñ-2), 119.25, 123.70, 126.12, 127.75 (Ñ-5, 7, 8, 4à); 141.98, 151.67 (Ñ-6, 8à); 174.06 – carbonyl C atom;
2
1
79.62, 181.36 – carboxylate C atoms.
-{[6-(3-Carboxylatopropanoyloxy)-2,5,7,8-tetramethylchroman-2-yl]methoxy}-4-oxobutanoicAcid (5). Alcohol
(54 mg, 0.23 mmol), succinic anhydride (68 mg, 0.68 mmol), DMAP (13 mg, 0.1 mmol), and Et N (32 ꢄL) in CH Cl (1 mL)
4
4
3
2
2
was stirred for 20–24 h at room temperature, washed with HCl solution (5%), dried over MgSO , and evaporated. Viscous
4
+
light-brown liquid, yield 76.8 mg (77%). Mass spectrum: found m/z 459.159 [M + Na] . C H O Na, calcd m/z: 459.163
2
2 28 9
+
–1
1
[
M + Na] . IR spectrum (ꢃ, cm ): 1713 (COÎH), 1730 and 1747 (ester COO). Í NMR spectrum (400 MHz, CDCl , ꢂ, ppm)
3
1
.25 (3Í, s, ÑÍ -2), 1.94, 1.98, 2.04 (each 3Í, s, ÑÍ -5, 7, 8), 1.71–1.79 (2Í, m, Í-3), 2.57–2.68 (6Í, m) – succinyl CH , 2.77–
3 3 2
13
2.80 (2Í, m, Í-4) and 2.88–2.91 (2Í, m) – succinyl CH , 4.14–4.23 (2Í, m, ÑÍ -2). C NMR spectrum (100 MHz, CD OD,
2
2
3
ꢂ, ppm): 11.89, 12.17, 13.05 (ÑÍ -5, 7, 8), 20.98, 22.22, 29.41, 29.70, 29.74, 29.76, 30.05 (Ñ-3, 4, ÑÍ -2, succinyl CH ),
3
3
2
6
9.63 (ÑÍ -2), 75.17 (Ñ-2), 118.64, 124.00, 126.46, 128.25 (Ñ-5, 7, 8, 4à), 142.34, 149.93 (Ñ-6, 8à), 173.24, 173.87 – carbonyl
2
C atoms, 175.75, 175.91 – carboxylate C atoms.
-Oxyl-2,2,6,6-tetramethylpiperidine-4-ammonium 4-{[6-(3-Carboxylatopropanoyloxy)-2,5,7,8-
tetramethylchroman-2-yl]methoxy}-4-oxobutanoate (6a). Orange powder, yield 35.8 mg (92%), mp 106.6–108.4°C.
1
–1
–
C H N O . IR spectrum (ꢃ, cm ): 1396 and 1637 (COÎ ), 1572 (ꢂN–H), 1740 (ester COO). EPR spectrum: à = 16.0 G.
40
66
4
11
N
bis(2-Hydroxyethyl)ammonium 4-{[6-(3-Carboxylatopropanoyloxy)-2,5,7,8-tetramethylchroman-2-
–
1
yl]methoxy}-4-oxobutanoate (6b). Viscous white liquid, yield 30.1 mg (93%). C H N O . IR spectrum (ꢃ, cm ): 1412
3
0 50 2 13
–
1
and 1619 (COÎ ), 1570 (ꢂN–H), 1738 (ester COO). Í NMR spectrum (500 MHz, CD OD, ꢂ, ppm, J/Hz): 1.30 (3Í, s,
3
ÑÍ -2), 1.98, 2.00, 2.07 (each 3Í, s, ÑÍ -5, 7, 8), 1.78–1.89 (1Í, m, ÑÍ -3), 2.46–2.53 (3Í, m), 2.60 (4Í, t, J = 6.5), 2.66
3
3
2
(
2Í, t, J = 6.8), 2.88 (2Í, t, J = 6.9) – Í-3, Í-4 and succinyl CH , 3.09–3.14 (8Í, m), 3.76–3.82 (8Í, m) – diethanolamine
2
1
3
CH , 4.07–4.18 (2Í, m, ÑÍ -2). C NMR spectrum (125 MHz, CD OD, ꢂ, ppm): 11.90, 12.25, 13.13 (ÑÍ -5, 7, 8), 20.99,
2
2
3
3
2
2.30, 29.46, 31.20, 31.41, 32.60 (Ñ-3, 4, ÑÍ -2, succinyl CH ), 50.49, 57.98 (diethanolamine CH ), 69.39 (ÑÍ -2), 75.19
3 2 2 2
(
1
Ñ-2), 118.67, 123.91, 126.52, 128.26 (Ñ-5, 7, 8, 4à), 142.43, 149.90 (Ñ-6, 8à), 173.89, 174.67 – carbonyl C atoms, 179.26,
79.41 – carboxylate C atoms.
-Oxyl-2,2,6,6-tetramethylpiperidine-4-ammonium 4-Oxo-4-[2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)
1
–
1
chroman-6-yloxy]butanoate (9a). Viscous orange liquid, yield 32.6 mg (93%). C H N O . IR spectrum (ꢃ, cm ): 1412
and 1631 (COÎ ), 1568 (ꢂN–H), 1749 (ester COO). EPR spectrum: à = 16.1 G.
4
2 73 2 6
–
N
(
2-Hydroxyethyl)ammonium 4-Oxo-4-[2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)chroman-6-
–1
yloxy]butanoate (9b). Viscous yellow liquid, yield 31.2 mg (98%). C H NO . IR spectrum (ꢃ, cm ): 1412 and 1620
COÎ ), 1570 (ꢂN–H), 1751 (ester COO). Í NMR spectrum (400 MHz, DMSO-d , ꢂ, ppm, J/Hz): 0.80–0.85 (12H, m) – alkyl
3
7
65
7
–
1
(
6
side-chain methyls, 0.99–1.57 (21Í, m) – alkyl side-chain methylenes and methines, 1.19 (3Í, s, ÑÍ -2), 1.89 (3Í, s), 1.91
3
(
3Í, s), 2.00 (3Í, s) – ÑÍ -5, 7, 8, 1.70–1.79 (2Í, m, Í-3), 2.51–2.57 (4Í, m), 2.77–2.82 (2Í, m) – Í-4 and succinyl CH
3
2
1
3
2
1
3
1
.72 (4Í, t, J = 5.5), 3.51 (4Í, t, J = 5.5) – diethanolamine CH2. C NMR spectrum (75 MHz, CDCl , ꢂ, ppm): 11.18, 11.40,
2.25 (ÑÍ -5, 7, 8), 19.01–19.22, 20.15, 20.59, 22.01, 22.10, 23.97, 24.37, 27.54, 29.40, 29.73, 30.71, 32.18–32.41,
6.79–37.20 (Ñ-3, 4, ÑÍ -2, succinyl CH and alkyl side-chain C atoms), 38.95, 56.70 (diethanolamine CH ), 74.75 (Ñ-2),
17.13, 122.57, 124.62, 126.31 (Ñ-5, 7, 8, 4à), 140.14, 148.97 (Ñ-6, 8à), 171.81 – carbonyl C atom, 175.97 – carboxylate C atom.
3
3
3
2
2
1
018